Annual meeting set for June 11, 2024; shareholder proposal deadlines announced

Lineage Cell Therapeutics, Inc.

2024 annual meeting of shareholders scheduled for June 11, 2024.
Shareholder business or director nominations due by March 15, 2024.
Shareholder proposals for proxy statement inclusion due by March 29, 2024.
Notices directed to Corporate Secretary at Carlsbad, CA address.

item 8.01

Lineage Cell Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-006901

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.